Comparing Donepezil vs Namenda XR
| Donepezil | Namenda XR (memantine) |
|
|---|
| Donepezil | Namenda XR (memantine) |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Donepezil boosts the effects of acetylcholine, a neurotransmitter that is noticeably depleted in people with Alzheimer's disease. Side effects are more likely at higher dosages and include nausea... View more |
Prescription only
Prescribed for Alzheimer's Disease. Namenda XR may also be used for purposes not listed in this medication guide. |
Related suggestions Popular comparisons
|
|||||||
| More about Donepezil | More about Namenda XR (memantine) | ||||||||
| Ratings & Reviews | |||||||||
|
Donepezil has an average rating of 5.8 out of 10 from a total of 143 ratings on Drugs.com. 45% of reviewers reported a positive effect, while 31% reported a negative effect. |
Namenda XR has an average rating of 5.2 out of 10 from a total of 6 ratings on Drugs.com. 50% of reviewers reported a positive effect, while 50% reported a negative effect. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
View all Donepezil side effects |
View all Namenda XR side effects |
||||||||
| Drug Class | |||||||||
| Generic Availability | |||||||||
|
Lower cost generic |
Lower cost generic approved | ||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||
View all Donepezil prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
| Dosage Forms | |||||||||
|
|
||||||||
| Brand Names | |||||||||
| Adlarity, Aricept, Aricept ODT | Other memantine brands include: Namenda | ||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
|
70 hours |
80 hours |
||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | |||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
||||||||
| Drug Interactions | |||||||||
|
A total of 527 drugs are known to interact with Donepezil:
|
A total of 43 drugs are known to interact with Namenda XR:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
| Disease Interactions | |||||||||
| First Approval Date | |||||||||
|
November 25, 1996 |
June 21, 2010 |
||||||||
| WADA Class View classifications | |||||||||
|
N/A |
N/A |
||||||||
| More Information | |||||||||
| Patient Resources | |||||||||
| Professional Resources | |||||||||
| Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Aricept
Aricept is used to treat mild to severe dementia caused by Alzheimer's disease. Learn about side ...
Namenda
Namenda is used to treat dementia associated with Alzheimer's disease. Learn about side effects ...
Botox
Botox is used cosmetically to reduce facial lines and wrinkles and for medical purposes for ...
Exelon
Exelon (rivastigmine) is used to treat dementia caused by Alzheimer's or Parkinson's disease ...
Leqembi
Leqembi (lecanemab) is used to treat Alzheimer’s disease to help slow the progression of dementia s ...
Namzaric
Namzaric (memantine/donepezil) is used to treat Alzheimer's Disease. Includes Namzaric side ...
Kisunla
Kisunla (donanemab) is a prescription medicine used for Alzheimer’s disease (AD) in patients with m ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.